Ratings by Stephens (Sudan Loganthan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Immunome Inc. | IMNM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/24/2025 | Pyxis Oncology Inc. | PYXS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/17/2025 | Immunome Inc. | IMNM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | Bicycle Therapeutics | BCYC | New Coverage | Equal Weight (N/A) |
23.64 (4.10) |
-82.66% | Details | |
| 11/8/2024 | Immunome Inc. | IMNM | New Coverage | Overweight (N/A) |
13.10 (19.96) |
52.37% | Details | |
| 11/8/2024 | Pyxis Oncology Inc. | PYXS | New Coverage | Overweight (N/A) |
4.02 (2.77) |
-31.09% | Details |
